Position in TCRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$18,321
-$91,752 QoQ
Shares Held
18,140
-70.0% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TCRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Virtu Financial LLC holds $48,959,238 across 141 Biotechnology names. TCRX ranks #120 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
70,715 | $3,728,094 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,634 | $3,408,886 | |
| 3 | CNTA |
Centessa Pharmaceuticals plc
|
67,775 | $2,692,023 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
54,785 | $2,204,000 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
38,479 | $2,173,678 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
262,298 | $2,011,825 | |
| 7 | ANAB |
Anaptysbio, Inc
|
33,323 | $1,848,091 | |
| 8 | ABVX |
Abivax S.A.
|
9,551 | $1,063,503 |
All Filings in TCRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,321 | 18,140 | Shares | Defined | 2026-05-14 | |
| 2025-09-30 | $110,073 | 60,480 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $16,512 | 11,388 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $15,211 | 11,023 | Shares | Defined | 2025-05-12 | |
| 2023-12-31 | $107,376 | 18,418 | Shares | Defined | 2024-02-26 | |
| No filing history on record for this holder in this stock. | ||||||